Maynard Um
-
-
-
-
-
-
-
GSK resubmits drug application for Spero's antibiotic treatment
-
-
-
-
-
-
-
SmartPros Ltd. (SPRO) Misses Q4 EPS by 2c
-
-
-
-
-
-
-
Spero Therapeutics (SPRO) Presents SPR719 In Vitro Data Demonstrating Low Propensity for the Development of Resistance
-
-
-
-
418,486 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

